BiotechTube
Home/Suntec Medical/Urban Skog
US

Urban Skog

Business Development

Suntec Medical

Therapeutic Areas

OncologyCentral Nervous SystemAutoimmuneCardiovascularInfectious DiseasesGene TherapyVaccines

Suntec Medical Pipeline

DrugIndicationPhase
MINC‑trastuzumabHER2‑positive breast cancerPreclinical
MINC‑sunitinibRenal cell carcinomaPreclinical
MINC‑doxorubicinVarious solid tumorsPreclinical
MINC‑anti‑CD3Autoimmune diseasesPreclinical

Leadership Team at Suntec Medical

PY
Pauline Y. Lau
CEO / Founder
BA
Bhuwnesh Agrawal
Corporate Executive Vice President, Strategy & BD
C(
Chun‑Ting (Isaac) Cheng
Pre‑clinical Development
YH
Yu‑Fang Hu
COO
View full Suntec Medical profile